Search

Your search keyword '"Bonniaud, Philippe"' showing total 276 results

Search Constraints

Start Over You searched for: Author "Bonniaud, Philippe" Remove constraint Author: "Bonniaud, Philippe" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
276 results on '"Bonniaud, Philippe"'

Search Results

3. Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial

5. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

6. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

8. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

9. French recommendations for the diagnosis and management of lymphangioleiomyomatosis

10. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version

12. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

13. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

14. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

15. Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial.

16. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

17. Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort

19. Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover

20. Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC

21. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

24. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

25. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

29. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

34. Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis

36. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.

37. Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab.

39. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

42. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis

44. HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling.

45. Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study.

Catalog

Books, media, physical & digital resources